G1 Therapeutics Inc (GTHX) is around the middle of the Biotechnology industry according to InvestorsObserver. GTHX received an overall rating of 39, which means that it scores higher than 39 percent of all stocks. G1 Therapeutics Inc also achieved a score of 40 in the Biotechnology industry, putting it above 40 percent of Biotechnology stocks. Biotechnology is ranked 55 out of the 148 industries.
GTHX has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on GTHX!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With G1 Therapeutics Inc Stock Today?
G1 Therapeutics Inc (GTHX) stock is trading at $1.51 as of 1:02 PM on Thursday, Nov 2, an increase of $0.16, or 12.31% from the previous closing price of $1.34. The stock has traded between $1.32 and $1.53 so far today. Volume today is below average. So far 408,425 shares have traded compared to average volume of 584,830 shares.
Click Here to get the full Stock Report for G1 Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
